Evaluation of Clinical-functional and Radiographic Outcomes in Patients Who Underwent Meniscal Allograft Transplantation (MAT) at 15 Years.

Launched by ISTITUTO ORTOPEDICO RIZZOLI · Jul 22, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how well patients who received a meniscal allograft transplantation (MAT) 15 years ago have done in terms of their knee function, pain levels, and any signs of arthritis. The meniscus is a crucial piece of cartilage in the knee that helps with movement and stability. After certain types of knee surgeries, some patients experience ongoing pain and swelling, a condition known as post-meniscectomy syndrome. MAT involves replacing the damaged meniscus with one from a donor, which can help restore knee function and potentially prevent arthritis.

To participate in this study, you need to be between 18 and 65 years old and have had meniscal transplantation surgery at the Rizzoli Orthopedic Institute at least 15 years ago. The researchers want to follow up with these patients to see how their knees are doing now. Participants will undergo evaluations to assess their knee health, and the findings will help improve future treatments for knee issues. The trial is currently recruiting, so if you meet the criteria and are interested, you may want to learn more about it.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged between 18 and 65 at the time of surgery
• • Both male and female
• • Patients who underwent meniscal transplantation at the Rizzoli Orthopedic Institute at least 15 years ago
• Exclusion Criteria:
• • Patients who do not give consent to be included in the study
• • Patients who are no longer reachable
• • Presence of infection or hematologic, rheumatic, or coagulation disorders at the time of evaluation